Transcat, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRNS research report →
Range $94 – $160
Price Chart
About the company
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
- CEO
- Jaime A. Irick
- IPO
- 1977
- Employees
- 1,413
- HQ
- Rochester, NY, US
Get TickerSpark's AI analysis on TRNS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $850.06M
- P/E
- 245.46
- Fwd P/E
- 47.93
- PEG
- -3.14
- P/S
- 2.44
- P/B
- 2.80
- EV/EBITDA
- 25.36
- Div Yield
- 0.00%
- Gross Margin
- 32.50%
- Op Margin
- 3.02%
- Net Margin
- 0.99%
- ROE
- 1.15%
- ROIC
- 1.41%
Latest fiscal year · YoY change
- Revenue
- $331.88M+19.2%
- Gross Profit
- $108.30M+21.1%
- Op Income
- $13.26M
- Net Income
- $5.38M-63.0%
- EPS
- $0.58-63.3%
- OCF Growth
- -10.6%
- FCF Growth
- -24.2%
- 52W High
- $100.00
- 52W Low
- $50.23
- 50D MA
- $88.30
- 200D MA
- $79.31
- Beta
- 0.67
- RSI (14)
- 58
- Avg Volume
- 125.13K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Transcat posted strong first-quarter growth, with Service revenue and margins leading the way and management reiterating confidence in full-year high-single-digit Service organic growth.· August 4, 2026
- Consolidated revenue rose 22% to $92.9 million, with consolidated gross profit up 19% to $30.7 million.
- Service revenue increased 27% and Service organic revenue grew 13%, marking the 69th straight quarter of year-over-year Service growth.
- Service gross profit rose 31% and Service gross margin expanded 90 basis points year over year.
- Adjusted EBITDA increased 19% to $14 million, while adjusted diluted EPS was $0.51 versus diluted EPS of $0.14.
- Management reiterated full-year expectations for high-single-digit Service organic growth and Service gross margin expansion, while keeping M&A central to strategy.
Transcat reported first-quarter fiscal 2027 consolidated revenue of $92.9 million, up 22% year over year, and consolidated gross profit of $30.7 million, up 19%. Diluted EPS was $0.14, while adjusted diluted EPS was $0.51. Adjusted EBITDA was $14 million, up 19% year over year. By segment, Service revenue grew 27% with 13% organic growth; Service gross profit rose 31% and Service gross margin expanded 90 basis points. Distribution revenue grew 11%, and Distribution gross margin was 31.4%, down 380 basis points year over year. Cash flow was also positive: operating free cash flow was $4.8 million, capital expenditures were $4 million, total debt was $110.4 million, available borrowings were $39.6 million, and leverage was 2.19x. For the full fiscal year, management said it expects high-single-digit Service organic growth and Service gross margin expansion, and it kept its tax rate outlook at 31% to 32%.
Jaime Irick said his first 100 days reinforced his confidence in Transcat’s growth opportunity and highlighted a need to become as strong on operational excellence as the company has been on growth. He emphasized levers such as customer process improvements, lean principles, pricing, mix optimization, and AI to support margin expansion and better customer solutions. His tone was constructive and optimistic, and he repeatedly pointed to strong end-market demand, share gains, and the company’s ability to grow both organically and through M&A.
Tom Barbato focused on the quarter’s financial drivers: strong Service performance, operating leverage, and productivity gains. He cited consolidated revenue of $92.9 million, gross profit of $30.7 million, adjusted EBITDA of $14 million, adjusted EPS of $0.51, and operating free cash flow of $4.8 million; he also noted $4 million of capex, $110.4 million of debt, $39.6 million of unused revolver capacity, and 2.19x leverage. On margins and taxes, he said Service gross margin expanded 90 basis points, Distribution gross margin was 31.4% because prior-year rebates were unusually high, and the full-year tax rate should normalize to 31% to 32%.
Analysts pressed management on why Service organic growth came in at 13% versus the implied high-single-digit full-year outlook, and management said performance was broad-based across end markets rather than driven by one area. They also asked about rental growth, with management saying it was in the expected high-single-digit to low-double-digit range, and about the timing of AI and operational-excellence benefits, which management said are already starting to lift results but will take time to fully show through. Other questions covered higher G&A and tax rate, both of which management tied mainly to CEO transition costs and stock-based compensation, and market share, where management said Transcat is still a small share of a large North American calibration market and is taking share broadly, especially as some competitors pull back.
The bull case from this call is that Transcat is still showing strong demand and share gains in highly regulated end markets, with Service growth accelerating to 13% organic and margins improving at the same time. Management sounded confident that operational excellence, pricing, mix optimization, and M&A can all contribute to further growth and margin expansion from here.
The main bear case is that some of the quarter’s EPS and G&A pressure came from acquisition-related amortization, stock comp, interest, and CEO transition costs, which can keep reported earnings below adjusted results. Distribution margins were down sharply versus an unusually strong prior-year comparison, and management said some of the new operational-excellence benefits are still early and will take time to fully materialize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.7%
- Shares Outstanding
- 9.36M
- Float Shares
- 9.14M
of shares held by institutions
162 13F filers
Buy/sell ratio 1.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Neuberger Berman Group LLC | 777.37K | ▼ 48.37K |
| Blackrock, Inc. | 727.01K | ▲ 52.09K |
| Hood River Capital Management LLC | 601.54K | ▼ 13.01K |
| Vanguard Group Inc | 530.78K | ▲ 11 |
| Ophir Asset Management Pty Ltd | 462.02K | ▼ 83.50K |
| Conestoga Capital Advisors, LLC | 449.56K | ▼ 62.96K |
| Royce & Associates LP | 431.67K | ▼ 182.58K |
| Vanguard Capital Management LLC | 414.06K | ▲ 6.90K |
| Barrow Hanley Mewhinney & Strauss LLC | 399.98K | ▲ 72.54K |
| Wellington Management Group Llp | 317.01K | ▲ 19.29K |
| Dimensional Fund Advisors LP | 275.30K | ▲ 13.26K |
| Paradice Investment Management LLC | 246.14K | ▼ 2.29K |
Held by 189 ETFs
Biggest fund positions in TRNS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 10, 26 | Mecca Robert | other | 1,587 |
| Sep 9, 26 | Mecca Robert | other | 1,671 |
| Sep 10, 26 | Mecca Robert | other | 1,587 |
| Sep 10, 26 | Langston Cynthia | other | 1,587 |
| Sep 9, 26 | Langston Cynthia | other | 1,671 |
| Sep 10, 26 | Langston Cynthia | other | 1,587 |
| Sep 10, 26 | Kaniki Mbago M. | other | 1,587 |
| Sep 9, 26 | Kaniki Mbago M. | other | 1,671 |
| Sep 10, 26 | Kaniki Mbago M. | other | 1,587 |
| Sep 10, 26 | Haseley Gary J. | other | 1,587 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TRNS coverage
Recent articles, reports, and earnings notes.
No research on TRNS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRNS report →Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued
gurufocus.com · Sep 23
Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point
seekingalpha.com · Sep 16
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
businesswire.com · Aug 31
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
businesswire.com · Aug 27
Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS
defenseworld.net · Aug 8
Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
seekingalpha.com · Aug 5
Transcat Q1 Earnings Call Highlights
marketbeat.com · Aug 4
Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates
zacks.com · Aug 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.